InvestSMART

Estia Health Limited (ASX: EHE) - Share Price

DELISTED - Current share price for EHE : $3.080

EHE General Information +

ASX Code EHE
Website N/A
Industry/Sector Health Care Facilities
Market Cap ($M) n/a
EHE Share Price $3.080
Day High $3.080
Day Low $3.070
Last Close $3.080
EHE Share Price Movement - ( No change )
Prices as at 16:35, 19 Dec 2023
+Security prices are delayed by at least 20 minutes and are indicative only.

Estia Health Limited (EHE) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 12¢ 100% 25 Aug 2023 15 Sep 2023 - - -
Result 3.7¢ 100% 24 Feb 2023 17 Mar 2023 - - -
Result 2.35¢ 100% 25 Feb 2022 18 Mar 2022 - - -

See all dividends from Estia Health Limited (EHE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Estia Health Limited (EHE) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Estia Health Limited (EHE)
ORDINARY FULLY PAID
 Health Care - Removal from Official List 18 Dec 2023 8:38AM $3.080 $3.080 fallen by 0%
Estia Health Limited (EHE)
ORDINARY FULLY PAID
 Health Care - Final Director's Interest Notice - Mr Paul Foster 15 Dec 2023 4:43PM $3.080 $3.080 fallen by 0%
Estia Health Limited (EHE)
ORDINARY FULLY PAID
 Health Care - Final Director's Interest Notice - Ms Karen Penrose 15 Dec 2023 4:43PM $3.080 $3.080 fallen by 0%
Estia Health Limited (EHE)
ORDINARY FULLY PAID
 Health Care - Final Director's Interest Notice - Ms Helen Kurincic 15 Dec 2023 4:43PM $3.080 $3.080 fallen by 0%
Estia Health Limited (EHE)
ORDINARY FULLY PAID
 Health Care - Final Director's Interest Notice - Dr Gary Weiss 15 Dec 2023 4:43PM $3.080 $3.080 fallen by 0%
Estia Health Limited (EHE)
ORDINARY FULLY PAID
 Health Care - Implementation of the Scheme of Arrangement 15 Dec 2023 4:31PM $3.080 $3.080 fallen by 0%

EHE Directors

Name Position Start Date
Mr Sean Bilton Chief Executive Officer, Managing Director 11 Jul 2022
Ms Norah Kathleen Barlow Non-Executive Director 17 Nov 2014
Professor Simon Willcock Non-Executive Director 1 Sep 2022

Estia Health Limited (EHE) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
2 Mar 2023 PENROSE, Karen Buy Indirect Shares 7,238 $2.070 $14,982.660
24 Feb 2023 WEISS, Gary Buy Indirect Shares 25,000 $2.070 $51,750.000
17 Nov 2022 BILTON, Sean Buy Direct Shares 48,623 $2.180 $105,998.140

See all changes in directors' interest & trades for Estia Health Limited (EHE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EHE Management

Name Position
Steve Lemlin Chief Financial Officer
Damian Hiser Chief Operating Officer
Leanne Ralph Company Secretary

EHE Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (EHE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
18,232,894 (6.97%) Citigroup Global Markets Australia Pty Limited
16,799,727 (6.46%) Milford Asset Management Limited
14,488,136 (5.61%) UBS Group AG and its related bodies corporate

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.